Moreover, it inhibits proliferation of cells derived from patients with glioblastoma [10] and the growth of tumors formed from neoplastic cell lines, such as Sarcoma-180 tumor cells [11], various neoplastic human and rodent cell lines [12], cells expressing the human epidermal growth factor receptor 2 (Her2/neu) [13], and HCT116 colon cancer cells [14]. Here, ERBB2 is linked to colonic neoplasm.